临床试验搜索

共显示 12 条结果

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Pfizer•Healthy

6 人入组2010年12月3日

Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered

Wyeth is now a wholly owned subsidiary of Pfizer•Healthy

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Pfizer•Alzheimer Disease

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer•Healthy

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

Wyeth is now a wholly owned subsidiary of Pfizer•Alzheimer Disease

32 人入组2007年5月28日

临床试验搜索

阶段

状态

地点

开始日期范围

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

临床试验搜索

临床试验搜索

阶段

状态

地点

开始日期范围

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531